Evidence map›Paper›PMID 25923438›Full record

ArticlePloS one2015

Chinese herbal therapy and Western drug use, belief and adherence for hypertension management in the rural areas of Heilongjiang province, China.

Xia Li, Mingkai Peng, Yuan Li, Zheng Kang, Yanhua Hao, Hong Sun, Lijun Gao, Mingli Jiao, Qunhong Wu, Hude Quan

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 3 pooled it
1.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 3 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Xia LiDepartment of Social Medicine, School of Public Health, Harbin Medical University, Harbin, China; College of Pharmacy, Harbin Medical University, Harbin, China.
Mingkai PengDepartment of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
Yuan LiDepartment of Social Medicine, School of Public Health, Harbin Medical University, Harbin, China.
Zheng KangDepartment of Social Medicine, School of Public Health, Harbin Medical University, Harbin, China.
Yanhua HaoDepartment of Social Medicine, School of Public Health, Harbin Medical University, Harbin, China.
Hong SunDepartment of Social Medicine, School of Public Health, Harbin Medical University, Harbin, China.
Lijun GaoDepartment of Social Medicine, School of Public Health, Harbin Medical University, Harbin, China.
Mingli JiaoDepartment of Social Medicine, School of Public Health, Harbin Medical University, Harbin, China.
Qunhong WuDepartment of Social Medicine, School of Public Health, Harbin Medical University, Harbin, China.
Hude QuanDepartment of Social Medicine, School of Public Health, Harbin Medical University, Harbin, China; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
Harbin Medical University · CNUniversity of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTraditional Chinese medicine (TCM) including Chinese herbal therapy has been widely practiced in China. However, little is known about Chinese herbal therapy use for hypertension management, which is one of the most prevalent chronic conditions in China. Thus we described Chinese herbal therapy and western drug users, beliefs, hypertension knowledge, and Chinese herbal and western drug adherence and determinants of Chinese herbal therapy use among patients with hypertension in rural areas of Heilongjiang Province, China. METHODOLOGY AND PRINCIPAL

findingsThis face-to-face cross sectional survey included 665 hypertensive respondents aged 30 years or older in rural areas of Heilongjiang Province, China. Of 665 respondents, 39.7% were male, 27.4% were aged 65 years or older. At the survey, 14.0% reported using Chinese herbal therapy and 71.3% reported using western drug for hypertension management. A majority of patients had low level of treatment adherence (80.6% for the Chinese herbal therapy users and 81.2% for the western drug users). When respondents felt that their blood pressure was under control, 72.0% of the Chinese herbal therapy users and 69.2% of the western drug users sometimes stopped taking their medicine. Hypertensive patients with high education level or better quality of life are more likely use Chinese herbal therapy. CONCLUSIONS AND SIGNIFICANCE: Majority of patients diagnosed with hypertension use western drugs to control blood pressure. Chinese herbal therapy use was associated with education level and quality of life.

Indexed as

Medicine, Chinese TraditionalAdultAgedAntihypertensive AgentsBlood PressureChinaCross-Sectional StudiesCultureDrugs, Chinese HerbalFemaleHumansHypertensionMaleMiddle AgedPatient ComplianceQuality of LifeAntihypertensive AgentsDrugs, Chinese Herbal

Identifiers

PMID25923438
PMCPMC4414607
OpenAlexW2093679471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.